In addition, mutation or inactivation of the EZH2 gene in myelodysplastic syndrome [124] and T-cell acute lymphoblastic leukemia (T-ALL) [125], where its tumor suppressor role is strongly supported. The gene discussed is EZH2; the disease is neoplasm.